RecruitingNCT06378944

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER


Sponsor

Omphis Foundation

Enrollment

15,000 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates using a special dye called indocyanine green to help surgeons more precisely identify and remove the sentinel lymph node (the first lymph node cancer might spread to) in breast cancer patients. Better sentinel node identification could help avoid unnecessary removal of many lymph nodes. **You may be eligible if...** - You are over 18 with a diagnosis of breast cancer - You are a candidate for sentinel lymph node detection (no cancer spread to underarm lymph nodes, or you had a good response to pre-surgery treatment) **You may NOT be eligible if...** - You have already had all the lymph nodes in your armpit removed (lymphadenectomy) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERApplication of green indocyanine colorant

The day of the surgery 1 ml of green indocyanine colorant will be applicated periareolar. After 5 minutes the lymph node will be detected and extracted

DRUGTechnetium99

Application of a periareolar injectionof TEchnetium 99 in order to detect the axillary lymph node


Locations(1)

Sandra Lopez Gordo

Cerdanyola del Vallès, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06378944


Related Trials